JPI InvestFranΓ§ais
JPI AI Analyst AI assistant Β· JPI Invest
Answers based on the tool's data Β· not financial advice Β· full analysis (free)
All stocks β€Ί Health Care β€Ί CNC

Are analysts right about Centene Corporation (CNC)?

Health Care Β· price $68.62 Β· median target $78.00 (+14%)
In short β€” Over the past 12 months, 39% of analyst price targets on Centene Corporation turned out profitable, for an average return of +9% (across 224 timestamped calls). The current consensus is "Hold" with a median price target of $78.00 (+14% vs the current $68.62, from 14 analysts).

πŸ“ˆ See the interactive version (live chart) β†’

πŸ”— Related pages on Centene Corporation β€” Financials & fundamentals  Β·  If I had invested
Current price
$68.62
Median target (12 mo)
$78.00 +14%
Analyst accuracy (1 yr)
39%
Avg return / call (1 yr)
+9%
πŸ’° Performance & Β« if I invested Β» πŸ“Š Interactive analysis

Historical analyst accuracy

For Centene Corporation, we replayed every analyst price target of the past 12 months and measured the real outcome: 39% were profitable, average return +9% (224 calls). At 3 months: +2% average return (41% profitable). The higher the %, the more often analysts were right on this stock.

Most reliable analysts on this stock (past track record)

Their past track record on this stock (targets replayed against real prices) β€” not a forecast of what will happen.

Analyst / brokerCalls i% profitable iAvg return i
Morgan Stanley2654%+12%
Barclays2119%-5%
Oppenheimer1942%+20%
Cantor Fitzgerald1926%-4%
Wells Fargo1612%-19%

Valuation

Is Centene Corporation overvalued, and is it a good time to buy Centene Corporation right now? If you're wondering, here's a recap to make up your own mind: Centene Corporation's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.

The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β€” but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.

MetricCentene CorporationSector median (Health Care)
P/E23.629.4
Forward P/E12.517.9
Net margin1%13%

πŸ‘‰ Centene Corporation trades below its sector median (23.6 vs 29.4) β€” potentially undervalued, or lower expected growth.

πŸ“– P/E, PEG, margin…: see the glossary

Frequently asked questions

Is Centene Corporation a buy right now?

The analyst consensus on Centene Corporation (CNC) is "Hold" (21 bullish, 1 bearish calls over 12 months). This is not advice: historically, 39% of their targets on this stock turned out profitable over 1 year.

What is Centene Corporation's price target?

The median 12-month price target is $78.00 (+14% vs $68.62), ranging from $63.00 to $82.00 (14 analysts).

Are analysts accurate on Centene Corporation?

Over 1 year, 39% of analyst targets on Centene Corporation were profitable, for an average return of +9% (across 224 timestamped calls). This is JPI Invest's accuracy metric.

What is the Centene Corporation stock forecast?

Analysts target a median of $78.00 within 12 months, i.e. +14% vs the current price. The most bullish targets $82.00, the most cautious $63.00.

What is the Centene Corporation stock forecast for 2026 or long term (2030)?

Note: analyst targets are 12-month (median $78.00, +14%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (39%), and the stock's past trajectory.

Is Centene Corporation overvalued?

Its P/E is 23.6, forward P/E 12.5. A forward P/E lower than the current P/E means earnings are expected to grow.

πŸ“Š See the full interactive analysis of Centene Corporation β†’

What is JPI Invest?

JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β€” on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.

Explore JPI Invest for free β†’ How it works: the method β†’

⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.